CXCL9 and neoplasm: We identified multiple tumor-immune interactions, for example between CXCR3, CCL5, TNFRSF1B, and VCAM1-expressing malignant T cells and macrophages/fibroblasts positive for CXCL9, CCR1, GRN, and IGTB1, respectively (Figure 4C).